Skin autofluorescence advanced glycosylation end products as an independent predictor of mortality in high flux haemodialysis and haemodialysis patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1797|20|11|862-867

ISSN： 1320-5358

Source： NEPHROLOGY, Vol.20, Iss.11, 2015-11, pp. : 862-867

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fixed payment for haemodialysis

By  

NEPHROLOGY, Vol. 20, Iss. 4, 2015-04 ,pp. : 243-249

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dalteparin Dosing in High-Flux Haemodialysis and Haemodiafiltration

By  

Nephron Clin Pract, Vol. 122, Iss. 1-2, 2013-03 ,pp. : 53-57

Karger

Access to resources Recommend Favorite

High cut‐off dialysis in chronic haemodialysis patients

By  

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol. 45, Iss. 12, 2015-12 ,pp. : 1333-1340

John Wiley & Sons Inc

Access to resources Recommend Favorite

End of life of patients treated with haemodialysis as narrated by their close relatives

By  

SCANDINAVIAN JOURNAL OF CARING SCIENCES, Vol. 29, Iss. 4, 2015-12 ,pp. : 776-784

John Wiley & Sons Inc

Access to resources Recommend Favorite

Skin Autofluorescence in HD Patients

By  

THERAPEUTIC APHERESIS AND DIALYSIS, Vol. 19, Iss. 1, 2015-02 ,pp. : 40-44

John Wiley & Sons Inc

Access to resources Recommend Favorite